Office of Science-Industry Partnerships

Our Vision

By developing collaborative relationships with industry, we will translate the work of our research investigators and clinicians into innovative products, devices and medical technology that will improve the lives of children and their families.

Partnering Opportunities

    Latest Partnerships

    We’re partnering with companies to turn discoveries into advances that transform pediatric health and well-being. Our latest partnerships include:

    • Developing cell therapies for acute myeloid leukemia with bluebird bio
    • Partnering with Moderna to investigate mRNA therapies for hemophilia A
    • Collaborating with Aptahem on aptamer-based treatments for sepsis
    • Investigating a GBS vaccine for pregnant women, with Minervax
    • Working with Nine to prevent stillbirth
    • Studying innovative weight-loss agents with OXT Therapeutics
    • Investigating the role of cadherin in disease
    • Collaborating with UCB to identify mechanisms behind intractable epilepsy
    • Working with Casebia Therapeutics to develop cell therapies for autoimmune disease
    • Investigating mRNA therapies developed by Moderna Therapeutics for rare genetic disorders
    • Creating a cost-effective, easy-to-use test for drug-resistant HIV, with help from InBios International
    • Collaborating with Immunexpress to pursue a screening test for sepsis

    Learn more about our latest partnerships.

    Contact Us

    Office of Science-Industry Partnerships

    For questions or inquiries,

    Physical Address

    818 Stewart St.
    Seattle, WA 98101

    Mailing Address

    M/S 818-S
    PO Box 5371
    Seattle, WA 98145-5005